| Literature DB >> 28828081 |
Fabián Rosas1, Rodrigo Ramírez-Campillo2,3, Cristian Martínez4, Alexis Caniuqueo5, Rodrigo Cañas-Jamet6,7, Emma McCrudden8, Cesar Meylan8,9, Jason Moran10, Fábio Y Nakamura11,12, Lucas A Pereira13, Irineu Loturco13, Daniela Diaz2, Mikel Izquierdo14,15.
Abstract
Plyometric training and beta-alanine supplementation are common among soccer players, although its combined use had never been tested. Therefore, a randomized, double-blind, placebo-controlled trial was conducted to compare the effects of a plyometric training program, with or without beta-alanine supplementation, on maximal-intensity and endurance performance in female soccer players during an in-season training period. Athletes (23.7 ± 2.4 years) were assigned to either a plyometric training group receiving a placebo (PLACEBO, n = 8), a plyometric training group receiving beta-alanine supplementation (BA, n = 8), or a control group receiving placebo without following a plyometric training program (CONTROL, n = 9). Athletes were evaluated for single and repeated jumps and sprints, endurance, and change-of-direction speed performance before and after the intervention. Both plyometric training groups improved in explosive jumping (ES = 0.27 to 1.0), sprinting (ES = 0.31 to 0.78), repeated sprinting (ES = 0.39 to 0.91), 60 s repeated jumping (ES = 0.32 to 0.45), endurance (ES = 0.35 to 0.37), and change-of-direction speed performance (ES = 0.36 to 0.58), whereas no significant changes were observed for the CONTROL group. Nevertheless, compared to the CONTROL group, only the BA group showed greater improvements in endurance, repeated sprinting and repeated jumping performances. It was concluded that beta-alanine supplementation during plyometric training may add further adaptive changes related to endurance, repeated sprinting and jumping ability.Entities:
Keywords: ergogenic aids; female athletes; muscle strength; strength training
Year: 2017 PMID: 28828081 PMCID: PMC5548158 DOI: 10.1515/hukin-2017-0072
Source DB: PubMed Journal: J Hum Kinet ISSN: 1640-5544 Impact factor: 2.193
Descriptive data of the control group (CONTROL, n = 9), plyometric training group receiving placebo (PLACEBO, n = 8) and plyometric training group receiving beta-alanine supplementation (BA, n = 8).
| CONTROL | PLACEBO | BA | |
|---|---|---|---|
| Age (y) | 24.0 ± 2.7 | 22.8 ± 2.1 | 24.3 ± 2.5 |
| Body mass (kg) | 58.5 ± 7.2 | 61.1 ± 8.3 | 58.1 ± 6.3 |
| Height (m) | 1.62 ± 0.04 | 1.64 ± 0.08 | 1.62 ± 0.05 |
| Body mass index (kg.m-2) | 22.2 ± 1.8 | 22.5 ± 1.2 | 22.0 ± 1.3 |
| Session rating of perceived exertion[ | 747 ± 267 | 690 ± 299 | 690 ±179 |
| Soccer experience (y) | 9.1 ± 3.9 | 7.5 ± 3.1 | 8.0 ± 3.8 |
| Competition games during the experimental period | 4.4 ± 2.1 | 4.8 ± 1.8 | 4.0 ± 2.2 |
| Weekly participation in other sport or training modalities (h) | 1.1 ± 0.6 | 1.1 ± 0.5 | 1.0 ± 0.3 |
| Energy intake (kcal·day-1) | 2,737 ± 339 | 2,456 ± 348 | 2,426 ± 255 |
| Carbohydrate intake (g·day-1) | 424 ± 77.6 | 356 ± 67.4 | 344 ± 73.8 |
| Lipid intake (g·day-1) | 80.7 ± 12.6 | 74.0 ± 14.7 | 68.6 ± 12.2 |
| Protein intake (g·day-1) | 80.0 ± 17.3 | 81.8 ± 8.8 | 86.4 ± 12.6 |
soccer training load was determined by multiplying the minutes of soccer training by the rating of perceived exertion after each soccer training session.
Training effects (with 95% confidence limits) for the jump performance variables for the control group (CONTROL, n = 9), plyometric training group receiving placebo (PLACEBO, n = 8) and plyometric training group receiving beta-alanine supplementation (BA, n = 8).
| Baseline Mean ± SD | Post Mean ± SD | Change (%) | Effect sizes | |
|---|---|---|---|---|
| Peak jump power (W) | ||||
| CONTROL | 2003 ± 341 | 1989 ± 272 | 0.0 (-5.7, 5.7) | 0.01 (-0.29, 0.27) |
| PLACEBO | 1974 ± 259 | 2140 ± 250 | 8.6 (5.2, 12.0)[ | 0.59 (0.41, 0.76) |
| BA | 1944 ± 340 | 2122±318 | 9.6 (5.6, 13.5)[ | 0.54 (0.36, 0.71) |
| Squat jump (cm) | ||||
| CONTROL | 25.4 ± 5.3 | 25.5 ± 4.9 | 0.8 (-1.6, 3.1) | 0.04 (-0.05, 0.12) |
| PLACEBO | 23.4 ± 2.4 | 25.0 ± 2.9 | 5.9 (3.0, 8.8)[ | 0.46 (0.28, 0.64) |
| BA | 25.4 ± 5.2 | 27.0 ± 5.5 | 6.1 (4.0, 8.1)[ | 0.27 (0.20, 0.34) |
| Countermovement jump (cm) | ||||
| CONTROL | 28.9 ± 5.8 | 29.4 ± 6.3 | 1.6 (-1.1, 4.3) | 0.07 (-0.03, 0.16) |
| PLACEBO | 24.8 ± 3.4 | 26.4 ± 3.0 | 8.7 (4.4, 12.9)[ | 0.56 (0.35, 0.76) |
| BA | 28.1 ± 3.5 | 30.6 ± 3.1 | 9.3 (6.1, 12.5)[ | 0.68 (0.50, 0.87) |
| 40 cm reactive strength index (mm.ms-1) | ||||
| CONTROL | 1.33 ± 0.3 | 1.33 ± 0.5 | -2.0 (-20.7, 16.7) | -0.12 (-0.52, 0.28) |
| PLACEBO | 1.24 ± 0.4 | 1.67 ± 0.6 | 36.6 (13.4,+59.8)[ | 0.74 (0.41, 1.08) |
| BA | 1.11 ± 0.2 | 1.53 ± 0.5 | 36.8 (18.3, 55.2)[ | 1.00 (0.67, 1.34) |
| 60 s countermovement jump power (W.kg-1) | ||||
| CONTROL | 15.3 ± 0.7 | 15.4 ± 0.8 | 0.9 (-0.2, 1.9) | 0.16 (0.0, 0.31) |
| PLACEBO | 15.1 ± 0.7 | 15.3 ± 0.7 | 1.7 (1.0, 2.4)[ | 0.32 (0.21, 0.43) |
| BA | 14.8 ± 1.0 | 15.3 ± 1.1 | 3.6 (2.3, 4.9)[ | 0.45 (0.32, 0.58)[ |
denote significant change pre to post training (p < 0.05 and p < 0.01, respectively).
denotes greater change compared to CONTROL (p < 0.05);
denote significant change pre to post training (p < 0.05 and p < 0.01, respectively).
denotes greater change compared to PLACEBO (p < 0.05);
denotes small meaningfully greater effect compared to PLACEBO.
Training effects (with 95% confidence limits) for the running anaerobic sprint test (RAST), change of direction speed, 20 m sprint and endurance performance for the control group (CONTROL, n = 9), plyometric training group receiving placebo (PLACEBO, n = 8) and plyometric training group receiving beta-alanine supplementation (BA, n = 8).
| Baseline Mean ± SD | Post Mean ± SD | Performance change(%) | Effect sizes | |
|---|---|---|---|---|
| RAST mean sprint time (s) | ||||
| CONTROL | 7.18 ± 0.9 | 7.17 ± 0.8 | -0.1 (-2.6, 2.4) | -0.01 (-0.17, 0.14) |
| PLACEBO | 7.49 ± 0.8 | 7.18 ± 0.6 | -4.0 (-6.8, -1.2)[ | -0.39 (-0.62, -0.17) |
| BA | 7.61 ± 0.5 | 7.10 ± 0.5 | -6.6 (-9.9, -3.3)[ | -0.91 (-1.27, -0.53)[ |
| 20 m sprint (s) | ||||
| CONTROL | 3.78 ± 0.3 | 3.83 ± 0.4 | 1.0 (-1.5, 3.5) | 0.1 (-0.11, 0.30) |
| PLACEBO | 3.89 ± 0.4 | 3.77 ± 0.4 | -3.3 (-5.4, -1.2)[ | -0.31 (-0.46, -0.15) |
| BA | 3.92 ± 0.2 | 3.80 ± 0.1 | -3.1 (-4.4, -1.3)[ | -0.78 (-1.05, -0.50) |
| Change of direction speed test time (s) | ||||
| CONTROL | 18.7 ± 0.4 | 18.7 ± 0.4 | -0.1 (-0.7, 0.6) | -0.02 (-0.25, 0.20) |
| PLACEBO | 18.5 ± 0.3 | 18.2 ± 0.4 | -1.3 (-1.8, -0.8)[ | -0.58 (-0.81, -0.44) |
| BA | 18.9 ± 0.7 | 18.6 ± 0.8 | -1.6 (-2.1, -1.1)[ | -0.36 (-0.45, -0.27) |
| 20 m multi stage shuttle run test (min) | ||||
| CONTROL | 7.9 ± 1.8 | 7.9 ± 2.0 | 0.3 (-5.9, 7.9) | 0.01 (-0.09, 0.10) |
| PLACEBO | 7.1 ± 1.1 | 7.5 ± 1.0 | 6.9 (0.0, 28.6)[ | 0.37 (0.07, 0.68) |
| BA | 7.9 ± 1.7 | 8.5 ± 1.7 | 8.8 (5.1, 13.0)[ | 0.35 (0.26, 0.44) |
denote significant change pre to post training (p < 0.05 and p < 0.01, respectively).
denote significant change pre to post training (p < 0.05 and p < 0.01, respectively).
denotes greater change compared to CONTROL (p < 0.05);
denotes greater change compared to PLACEBO (p < 0.05);
denotes small meaningfully greater effect compared to PLACEBO.